1-oxido-4-({3-[(4-oxo-4-{[(1S,4S,5R,8S,9R,10S,12R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-yl]oxy}butanoyl)oxy]-2-{[(4-oxo-4-{[(1S,4S,5R,8S,9R,10S,12R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-yl]oxy}butanoyl)oxy]methyl}propoxy}carbonyl)pyridin-1-ium

ID: ALA3038219

Chembl Id: CHEMBL3038219

PubChem CID: 73354259

Max Phase: Preclinical

Molecular Formula: C48H65NO19

Molecular Weight: 960.04

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1[C@H](OC(=O)CCC(=O)OCC(COC(=O)CCC(=O)O[C@@H]2O[C@@H]3O[C@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)COC(=O)c2cc[n+]([O-])cc2)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3

Standard InChI:  InChI=1S/C48H65NO19/c1-26-7-9-34-28(3)41(61-43-47(34)32(26)15-19-45(5,63-43)65-67-47)59-38(52)13-11-36(50)56-23-30(25-58-40(54)31-17-21-49(55)22-18-31)24-57-37(51)12-14-39(53)60-42-29(4)35-10-8-27(2)33-16-20-46(6)64-44(62-42)48(33,35)68-66-46/h17-18,21-22,26-30,32-35,41-44H,7-16,19-20,23-25H2,1-6H3/t26-,27-,28-,29-,32+,33+,34+,35+,41-,42-,43-,44-,45+,46+,47-,48-/m1/s1

Standard InChI Key:  KMFWXHCWCVOMJA-HEZKWCNDSA-N

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRAMP-C1A (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2D cell line (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2G cell line (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRAMP-C2H (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 960.04Molecular Weight (Monoisotopic): 959.4151AlogP: 5.24#Rotatable Bonds: 15
Polar Surface Area: 232.28Molecular Species: NEUTRALHBA: 19HBD:
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): #RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 0.62CX LogP: 5.71CX LogD: 5.71
Aromatic Rings: 1Heavy Atoms: 68QED Weighted: 0.07Np Likeness Score: 1.14

References

1. Posner GH, McRiner AJ, Paik IH, Sur S, Borstnik K, Xie S, Shapiro TA, Alagbala A, Foster B..  (2004)  Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.,  47  (5): [PMID:14971910] [10.1021/jm0303711]

Source